Here's Why Mirati Therapeutics Is Surging Today

Here's Why Mirati Therapeutics Is Surging Today

Source: 
Motley Fool
snippet: 

Shares of Mirati Therapeutics (NASDAQ: MRTX), a clinical-stage biotechnology company developing new cancer drugs, are on the move thanks to enthusiasm for its experimental KRAS inhibitor.